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Summary
The efficacy of Fusobacterium necrophorum crude leukotoxoid vaccine to immunize and protect steers against experimentally induced liver abscesses was evaluated. The vaccine consisted of cell-free culture supernatant of a high leukotoxinproducing strain of F. necrophorum, inactivated with formalin and homogenized with an oil emulsion adjuvant. Vaccine was injected subcutaneously on days 0 and 21. Blood samples were collected weekly to monitor immune response. Three weeks after the second vaccination, steers were injected intraportally with F. necrophorum culture to induce liver abscesses. Three weeks later (day 63), steers were euthanatized and necropsied; livers were examined, and protection was assessed. Anti-leukotoxin antibody titers in the control steers generally did not differ from the baseline (week 0) titers. The titers in the vaccinated groups increased, more so after the second injection, and the increase was generally dose dependent. At necropsy, all steers in the control group had liver abscesses. In the vaccinated groups, two out of five steers in the 1.0 ml group and one each in the 2.0, 5.0, and 2.25 ml (concentrated) groups had liver abscesses. The difference suggests a protective effect of antileukotoxin antibodies against experimentally induced liver abscesses.
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Introduction
Liver abscesses are of economic concern to the feedlot industry because they cause liver condemnation, reduced feed efficiency, and reduced weight gain. Fusobacterium necrophorum, is the primary causative agent of liver abscesses. The incidence of liver abscesses averages 18 to 32% in feedlot cattle and is related to feeding high grain diets. Rapid ruminal fermentation of grain in the rumen results in ruminal acidosis and rumenitis, which are considered to be predisposing factors for liver abscesses. Fusobacterium necrophorum, a normal inhabitant of the rumen, colonizes the ruminal epithelial wall, reaches the liver via the portal circulation, and sets up infection. The ability of F. necrophorum to colonize ruminal epithelium and establish infection in the liver is attributed mainly to a potent leukotoxin that is toxic to leukocytes, macrophages, ruminal epithelial cells, and hepatocytes. Therefore, immunizing the animal against the toxin may prevent the onset of liver abscesses. Our
The leukotoxin concentration in the objective was to determine the efficacy of F.
original culture supernatant was 27,020 necrophorum leukotoxoid vaccine to immu-units/ml. In the culture supernatant concennize steers and to provide protection against trated 5.2-fold, the leukotoxin concentration experimentally induced liver abscesses.
was 54,040 units/ml. Apparently, the process
Experimental Procedures
Fusobacterium necrophorum, A25, a leukotoxin concentration in the 4.5 ml dose. high leukotoxin producing strain, previously isolated from a liver abscess was used to Antibody titers in the control steers inprepare the vaccine, which consisted of cell-jected with phosphate-buffered saline generfree supernatant (original or concentrated ally did not differ from the baseline through-5.2 fold) inactivated by adding formalin and out the 6-week sampling period. The titers in homogenized with an oil emulsion adjuvant.
the vaccinated steers increased (P<.01) folThe leukotoxicity of the original and concenlowing the first vaccination and increased trated culture supernatants, before and after much more after the second injection (Figure formalin inactivation, was determined. 1). A significant treatment x week interacTwenty-five Holstein steers (mean body body titers appeared to be related to the dose weight 860 lb), fed ad libitum a diet of alfalfa of leukotoxoid, with the 1.0 ml dose eliciting hay, were assigned randomly to five groups: the lowest antibody titers and the 5.0 ml dose control; three doses (1.0, 2.0, and 5.0 ml) of eliciting the highest. The purpose of using the the culture supernatant; and a dose of the concentrated supernatant was to determine concentrated supernatant (2.25 ml) equivawhether concentrating the culture supernatant lent to the leukotoxin concentration in 4.5 ml to reduce the injection volume would alter its of the original culture supernatant (Table 1) .
immunogenicity or protective effect. ApparEach steer in the control group received 4.5 ently, concentrating the culture supernatant ml of phosphate buffer saline mixed with reduced its immunogenicity as evidenced by adjuvant. All injections were given subcutalower antibody titers. neously on days 0 and 21. Jugular blood samples were collected at group had liver abscesses as compared to two weekly intervals after the first vaccination to out of five steers in the 1.0-ml-vaccinated monitor the immune response. Serum samgroup and one each in the 2.0, 5.0, and 2.25 ples were assayed for anti-leukotoxin antiml (concentrated) groups (Table 2) . Based body titers. Three weeks after the second on Fisher's exact test (2-tail), the incidence of vaccination, steers were inoculated intraliver abscesses was lower (P<0.01) in the portally by an ultrasound-guided, percutvaccinated groups (all four doses) than in the aneous, catheterization procedure with F.
control. Steers that developed abscesses necrophorum to induce liver abscesses (n=10) had lower anti-leukotoxin titers Steers were euthanatized 21 days after the (P<0.05) during wk 1 to 6 than those steers intraportal challenge and examined for abscesses and other gross lesions in the liver and other organs.
Results and Discussion
of concentration reduced the leukotoxin activity. Therefore, 2.25 ml of the concentrated supernatant was used to equal the tion (P < .01) occurred. Generally, the antiAt necropsy, all five steers in the control (n=15) that did not develop abscesses in the liver, regardless of the treatment (Figure 2 
